July 2018

UR CTSI Joins Effort to Expand Experimental Treatment Access to Desperately Ill Patients

The University of Rochester Clinical and Translational Science Institute (UR CTSI) is part of a national effort to help hospitals offer experimental treatments to patients via the FDA’s Expanded Access process and improve how data is tracked from these patients.

Four Ways Academic Organizations Can Boost Clinical Trial Results Reporting

Academic research organizations struggle to comply with expanding federal requirements for registering and reporting results of clinical trials. Luckily, a recent survey suggests four things organizations can do right now to boost compliance.

UR CTSI Regulatory Science Competition Winner Visits the FDA

The winner of the local America’s Got Regulatory Science Talent Competition visited the FDA in April to present her winning proposal: a database to help identify new uses for FDA-approved drugs.